Functional genomic and high-content screening for target discovery and deconvolution

Author： Heynen-Genel Susanne Pache Lars Chanda Sumit K Rosen Jonathan

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.10, 2012-01, pp. : 955-968

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-content siRNA screening for target identification and validation

By Krausz Eberhard Korn Kerstin

Expert Opinion on Drug Discovery, Vol. 3, Iss. 5, 2008-05 ,pp. : 551-564

Informa Healthcare

Access to resources Recommend Favorite

High-content screening in microfluidic devices

By Cheong Raymond Paliwal Saurabh Levchenko Andre

Expert Opinion on Drug Discovery, Vol. 5, Iss. 8, 2010-08 ,pp. : 715-720

Informa Healthcare

Access to resources Recommend Favorite

High-content screening for the discovery of pharmacological compounds: advantages, challenges and potential benefits of recent technological developments

By Soleilhac Emmanuelle Nadon Robert Lafanechere Laurence

Expert Opinion on Drug Discovery, Vol. 5, Iss. 2, 2010-02 ,pp. : 135-144

Informa Healthcare

Access to resources Recommend Favorite

Computational methods to support high-content screening: from compound selection and data analysis to postulating target hypotheses

By Kümmel Anne Gabriel Daniela Parker Christian N Bender Andreas

Expert Opinion on Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 5-13

Informa Healthcare

Access to resources Recommend Favorite

Genomic and Proteomic Screening of Apoptosis Mitochondrial Regulators for Drug Target Discovery

Current Medicinal Chemistry, Vol. 14, Iss. 8, 2007-04 ,pp. : 875-881

Bentham Science Publishers

Access to resources Recommend Favorite